UNIVERSAL IBOGAINE INC (IBO.CA) Stock Fundamental Analysis

TSX-V:IBO • CA91360F1099

0.005 CAD
0 (-50%)
Last: Feb 2, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

0

IBO gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of IBO have multiple concerns. IBO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year IBO has reported negative net income.
  • IBO had a negative operating cash flow in the past year.
IBO.CA Yearly Net Income VS EBIT VS OCF VS FCFIBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -36.85%
ROE -542.4%
ROIC N/A
ROA(3y)-85.01%
ROA(5y)N/A
ROE(3y)-203.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBO.CA Yearly ROA, ROE, ROICIBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

  • The Profit Margin and Operating Margin are not available for IBO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBO.CA Yearly Profit, Operating, Gross MarginsIBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • IBO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IBO has more shares outstanding
  • The debt/assets ratio for IBO is higher compared to a year ago.
IBO.CA Yearly Shares OutstandingIBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 100M 200M 300M
IBO.CA Yearly Total Debt VS Total AssetsIBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • Based on the Altman-Z score of -9.97, we must say that IBO is in the distress zone and has some risk of bankruptcy.
  • IBO has a Debt/Equity ratio of 6.33. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 6.33
Debt/FCF N/A
Altman-Z -9.97
ROIC/WACCN/A
WACC5.64%
IBO.CA Yearly LT Debt VS Equity VS FCFIBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

  • IBO has a Current Ratio of 0.39. This is a bad value and indicates that IBO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IBO has a Quick Ratio of 0.39. This is a bad value and indicates that IBO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
IBO.CA Yearly Current Assets VS Current LiabilitesIBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 22.39% over the past year.
  • IBO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.69%.
EPS 1Y (TTM)22.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
Revenue 1Y (TTM)-11.69%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%30.59%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IBO.CA Yearly Revenue VS EstimatesIBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • IBO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IBO.CA Price Earnings VS Forward Price EarningsIBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IBO.CA Per share dataIBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for IBO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UNIVERSAL IBOGAINE INC

TSX-V:IBO (2/2/2026, 7:00:00 PM)

0.005

0 (-50%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.44%
Ins Owner ChangeN/A
Market Cap1.56M
Revenue(TTM)2.06M
Net Income(TTM)-1.48M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 5.75
P/tB 5.75
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.85%
ROE -542.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.31%
FCFM N/A
ROA(3y)-85.01%
ROA(5y)N/A
ROE(3y)-203.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 6.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.99%
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z -9.97
F-Score3
WACC5.64%
ROIC/WACCN/A
Cap/Depr(3y)60.13%
Cap/Depr(5y)N/A
Cap/Sales(3y)15.75%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.69%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%30.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.58%
OCF growth 3YN/A
OCF growth 5YN/A

UNIVERSAL IBOGAINE INC / IBO.CA FAQ

What is the ChartMill fundamental rating of UNIVERSAL IBOGAINE INC (IBO.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to IBO.CA.


What is the valuation status for IBO stock?

ChartMill assigns a valuation rating of 0 / 10 to UNIVERSAL IBOGAINE INC (IBO.CA). This can be considered as Overvalued.


What is the profitability of IBO stock?

UNIVERSAL IBOGAINE INC (IBO.CA) has a profitability rating of 0 / 10.